ロード中...
In Vitro Metabolism and Stability of the Actinide Chelating Agent 3,4,3-LI(1,2-HOPO)
The hydroxypyridinonate ligand 3,4,3-LI(1,2-HOPO) is currently under development for radionuclide chelation therapy. The preclinical characterization of this highly promising ligand comprised the evaluation of its in vitro properties, including microsomal, plasma, and gastrointestinal fluid stabilit...
保存先:
| 出版年: | J Pharm Sci |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4390475/ https://ncbi.nlm.nih.gov/pubmed/25727482 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.24394 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|